A detailed history of Bare Financial Services, Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Bare Financial Services, Inc holds 21 shares of AXSM stock, worth $2,933. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21
Previous 10 110.0%
Holding current value
$2,933
Previous $1.04 Million 144.25%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$100.39 - $129.29 $1,104 - $1,422
11 Added 110.0%
21 $2.55 Million
Q2 2025

Aug 13, 2025

BUY
$95.65 - $116.49 $956 - $1,164
10 New
10 $1.04 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $5.99B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Bare Financial Services, Inc Portfolio

Follow Bare Financial Services, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bare Financial Services, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bare Financial Services, Inc with notifications on news.